Rockwell Automation Opens Experience Center at Advanced Regenerative Manufacturing Institute

News
Article

The Rockwell Experience Center will teach ARMI members how to increase delivery speeds by leveraging smart manufacturing in the scaling of regenerative medicine products.

Rockwell Automation announced the grand opening of the Rockwell Experience Center at the Advanced Regenerative Manufacturing Institute (ARMI), in Manchester, N.H. on June 8, 2022. The Rockwell Experience Center is designed to teach its ARMI members how to increase delivery speeds by leveraging smart manufacturing in the scaling of regenerative medicine products. ARMI is a member-based, nonprofit organization whose goal is to advance the bioeconomy of the United States.

According to a company press release, the focal point of the center is a fully automated Cytiva equipment process train that is integrated with various Rockwell technologies, including a distributed control system, a manufacturing execution system, and a digital twin. The center also contains equipment from Air Science, Fester, and HID Global.

“To say that the addition of the Rockwell Experience Center at the ARMI|BioFabUSA facility will be impactful to the area of regenerative medicine would be an understatement,” said Dean Kamen, executive director of ARMI, in the press release. “By opening this center, we are able to demonstrate the baseline tools by which different types of human tissues and organs can be manufactured at scale. It's life-changing.”

“The Rockwell Experience Center demonstrates Rockwell’s long-standing support of ARMI and the role smart manufacturing technologies can play to bring regenerative medicine to scale,” said Blake Moret, ARMI board member and chairman, and CEO, Rockwell Automation, in the press release. “ARMI’s work training workers to compete and win in this fast-moving industry is an exciting model for manufacturing and for American competitiveness.”

Source: Rockwell Automation

Recent Videos
Tore Bergsteiner from MAIN5 discusses the most pertinent and impactful bio/pharma industry trends from 2024.
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Related Content